🇳🇬 #7 Export Destination

Nigeria

India's pharmaceutical partnership with Nigeria

$727M FY 2025–26

India ships $727M in pharmaceutical products to Nigeria each year, making it the #7 export destination. Exports have grown 2.1× over the past decade.

All data from DGCIS India export records (fiscal year, April–March).
$727M
Scale
India supplies $727M in pharmaceutical products to Nigeria each year, a substantial supply line of affordable medicine.
66%
Medicine
Primarily medicines (66%), supplemented by vaccines and medicine ingredients.
2.1×
Trajectory
India's pharmaceutical supply to Nigeria has grown 2.1× over the past decade, strong, sustained expansion.
#7
Context
A top-10 export destination, and a key pharmaceutical market in Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Nigeria, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $482M (66.2%) Vaccines $169M (23.2%) Medicine Ingredients $64.4M (8.9%) Surgical & Hospital Supplies $6.4M (0.9%) Traditional & Herbal $5.9M (0.8%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Nigeria Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Nigeria: $17.0M across 36 filings (2011-2025).